HeartSciences Inc. (HSCS)
NASDAQ: HSCSHealth CareIndustrial SpecialtiesUSD
Market open · Delayed 15 min · as of Oct 9, 9:46 AM ET
HSCS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $15.50M
- EPS (TTM)
- -$3.21
- Dividend yield
- None
- 52-week range
- 1.63 – 5.25
- Day range
- 3.15 – 3.31
- Volume / Avg
- 20.94K / 154.08K
- Beta
- —
- Shares outstanding
- 4.84M
52-week range
HSCS stock today
On Oct 9, HSCS is trading at $3.20, adding $0.16 (5.26%), versus the S&P 500's 0.25% gain. Shares are 39.0% below their 52-week high of $5.25, set on Sep 21, 2026 and 96.3% above the 52-week low of $1.63, in the middle of the past year's range. HSCS is down 1.6% year to date, underperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has lost 18.3%.
HeartSciences has posted a net loss over the last twelve months (EPS of -$3.21), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About HeartSciences
Company profileHeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. Andrew Simpson
- Headquarters
- Southlake, TX
- Employees
- 14
- IPO year
- 2022
- Website
- heartsciences.com
Analyst forecast
ForecastConsensus (1 analysts)
buy
Avg. price target
$12.00+275.00%
- Strong buy 1
- Buy 0
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
HeartSciences peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| FGIFGI Industries Ltd. | 7.77 | -0.64% | $15.01M | vs HSCS |
| CUPRCuprina Holdings (Cayman) Limited Class A | 1.82 | -4.21% | $12.75M | vs HSCS |
| TLIHTen-League International Holdings Limited | 5.75 | 0.00% | $16.91M | vs HSCS |
| RGNTRegentis Biomaterials Ltd. | 1.67 | -1.76% | $11.73M | vs HSCS |
| LFWDLifeward Ltd. | 6.61 | +2.80% | $18.72M | vs HSCS |
| CLGNCollPlant Biotechnologies Ltd | 3.88 | -2.27% | $7.34M | vs HSCS |
| BBLGBone Biologics Corp | 0.4705 | +0.30% | $1.30M | vs HSCS |
| MLSSMilestone Scientific Inc. | 0.36 | 0.00% | $32.62M | vs HSCS |
Indexes, lists and sector
HeartSciences stock FAQ
What is HeartSciences's stock price today?
HSCS last traded at $3.20 as of Oct 9, 9:46 AM EDT, up 5.26% on the day. Prices are delayed at least 15 minutes.
Does HeartSciences pay a dividend?
No. HeartSciences does not currently pay a regular cash dividend.
Who is HeartSciences's CEO?
Mr. Andrew Simpson is the chief executive officer of HeartSciences Inc., which has about 14 employees.
Has HSCS ever split its stock?
Yes. The most recent HSCS stock split was a 1-for-100 split on May 17, 2024.
What is the HSCS 52-week high?
The 52-week high for HSCS is $5.25 and the 52-week low is $1.63. The stock is currently 39.0% below its high.